Invention Grant
US09266882B2 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
有权
咪唑并[1,2-a]吡啶衍生物：制备和药物应用
![Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications](/docs/US/2016-02-23/US09266882B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
- Patent Title (中): 咪唑并[1,2-a]吡啶衍生物：制备和药物应用
-
Application No.: US14517614Application Date: 2014-10-17
-
Publication No.: US09266882B2Publication Date: 2016-02-23
- Inventor: Ken Chi Lik Lee , Eric T. Sun , Haishan Wang
- Applicant: MEI Pharma, Inc.
- Applicant Address: US CA San Diego
- Assignee: MEI PHARMA, INC.
- Current Assignee: MEI PHARMA, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D498/02 ; C07D491/02 ; C07D471/04
![Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications](/abs-image/US/2016/02/23/US09266882B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to imidazo[1,2-a]pyridine containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities (HDAC).
Public/Granted literature
- US20150038703A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS Public/Granted day:2015-02-05
Information query
